Younis Husam's Form 4 filing
Atrium Therapeutics, Inc. (RNA) · filed Sep 22, 2026
- Accession no.
- 0001193125-26-397971
- Filed
- Sep 22, 2026, 4:24 PM ET
- Trade date
- Sep 18, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Younis HusamCIK 0002107586 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Common Stock | FTax withholdingDisposed | −11,216 | $8.95 | −$100,383.2 | 41,441 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.